{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T21:09:08Z","timestamp":1788815348596,"version":"build-2803163510"},"reference-count":24,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T00:00:00Z","timestamp":1781654400000},"content-version":"vor","delay-in-days":7,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Cancer National Institute","award":["Unit U1086 ANTICIPE"],"award-info":[{"award-number":["Unit U1086 ANTICIPE"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,6,10]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Organized breast cancer screening programmes are a cornerstone of cancer control policy across Europe. Population-based cancer registries (PBCRs) play a central role in monitoring screening performance, outcomes, and programme quality. However, the extent and methodological approaches of registry-based evaluations across Europe have not been comprehensively synthesized. Following PRISMA-ScR guidelines, we conducted a scoping review of peer-reviewed studies evaluating organized breast cancer screening programmes in Europe using PBCR data. Studies were identified through systematic database searches and screened using predefined eligibility criteria. Data were extracted on study design, definitions of detection mode, outcome measures, and approaches to bias adjustment. The Reach, Effectiveness, Adoption, Implementation, and Maintenance (RE-AIM) framework guided the methodological analysis. Twenty-six studies were included, mainly from Western and Northern Europe, with most published before 2010. Screen-detected cancers consistently showed lower mortality, better survival, and more favourable tumour characteristics than interval or non-screened cancers. However, reporting of screening indicators was inconsistent. Definitions of detection modes, particularly interval cancers, and approaches to bias adjustment varied widely, limiting comparability. Few studies applied comprehensive bias correction or clearly reported registry\u2013screening data linkage. Registry-based evaluations provide valuable evidence on the impact of breast cancer screening programmes, However, the evidence is limited by methodological heterogeneity and limited analytical standardization, reducing its comparability and policy relevance. Strengthening standardized definitions, improving transparency in analytical approaches, and better integrating programme monitoring with research could enhance the public health value of registry-based screening evaluation.<\/jats:p>","DOI":"10.1093\/eurpub\/ckag090","type":"journal-article","created":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T11:47:06Z","timestamp":1780055226000},"source":"Crossref","is-referenced-by-count":0,"title":["Use of population-based cancer registry data to evaluate organized breast cancer screening programmes in Europe by mode of detection: a scoping review"],"prefix":"10.1093","volume":"36","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-9565-3958","authenticated-orcid":false,"given":"Wendy","family":"Kam","sequence":"first","affiliation":[{"name":"Public Health, U1086 \u2018ANTICIPE\u2019 INSERM\u2014University of Caen Normandie, B\u00e2timent Biologie Recherche, CHU de Caen , Caen,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elodie","family":"Guillaume","sequence":"additional","affiliation":[{"name":"Public Health, U1086 \u2018ANTICIPE\u2019 INSERM\u2014University of Caen Normandie, B\u00e2timent Biologie Recherche, CHU de Caen , Caen,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quentin","family":"Rollet","sequence":"additional","affiliation":[{"name":"Public Health, U1086 \u2018ANTICIPE\u2019 INSERM\u2014University of Caen Normandie, B\u00e2timent Biologie Recherche, CHU de Caen , Caen,","place":["France"]},{"name":"Department of Precision Health (DoPH), Cancer Epidemiology and Prevention Group (EPICAN), Luxembourg Institute of Health (LIH) , Strassen,","place":["Luxembourg"]},{"name":"Registre National du Cancer du Luxembourg, RNC , Strassen,","place":["Luxembourg"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dafina","family":"Petrova","sequence":"additional","affiliation":[{"name":"Cancer Registry of Granada, Escuela Andaluza de Salud P\u00fablica , Granada,","place":["Spain"]},{"name":"Escuela Andaluza de Salud P\u00fablica, Instituto de Investigaci\u00f3n Biosanitaria ibs , Granada,","place":["Spain"]},{"name":"Instituto de Investigaci\u00f3n Biosanitaria, University of Granada , Granada,","place":["Spain"]},{"name":"University Hospital Virgen de las Nieves, Department of Preventive Medicine and Public Health , Granada,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicol\u00e1s Francisco","family":"Fern\u00e1ndez-Mart\u00ednez","sequence":"additional","affiliation":[{"name":"Escuela Andaluza de Salud P\u00fablica, Instituto de Investigaci\u00f3n Biosanitaria ibs , Granada,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0717-2406","authenticated-orcid":false,"given":"Koen","family":"van Herck","sequence":"additional","affiliation":[{"name":"Belgian Cancer Registry, Universiteit Antwerpen , Brussels,","place":["Belgium"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mari\u00e0","family":"Carulla","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, Regional Health Council, IMIB-Arrixaca, Murcia University , Murcia,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Pla","sequence":"additional","affiliation":[{"name":"Cancer Epidemiology and Prevention Service, Hospital Universitari Sant Joan de Reus, IISPV , Reus,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francina","family":"Saladi\u00e9","sequence":"additional","affiliation":[{"name":"Cancer Epidemiology and Prevention Service, Hospital Universitari Sant Joan de Reus, IISPV , Reus,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Miracle","sequence":"additional","affiliation":[{"name":"Hospitalet de Llobregat, Catalan Institute of Oncology (ICO), Catalu\u00f1a, Espa\u00f1a"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vesna","family":"Zadnik","sequence":"additional","affiliation":[{"name":"Slovenian Cancer Registry, Institute of Oncology , Ljubljana,","place":["Slovenia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonja","family":"Tom\u0161i\u010d","sequence":"additional","affiliation":[{"name":"Slovenian Cancer Registry, Institute of Oncology , Ljubljana,","place":["Slovenia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Cowppli-Bony","sequence":"additional","affiliation":[{"name":"Belgian Cancer Registry, Universiteit Antwerpen , Brussels,","place":["Belgium"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guy","family":"Launoy","sequence":"additional","affiliation":[{"name":"Public Health, U1086 \u2018ANTICIPE\u2019 INSERM\u2014University of Caen Normandie, B\u00e2timent Biologie Recherche, CHU de Caen , Caen,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudine","family":"Backes","sequence":"additional","affiliation":[{"name":"Department of Precision Health (DoPH), Cancer Epidemiology and Prevention Group (EPICAN), Luxembourg Institute of Health (LIH) , Strassen,","place":["Luxembourg"]},{"name":"Registre National du Cancer du Luxembourg, RNC , Strassen,","place":["Luxembourg"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,6,17]]},"reference":[{"key":"2026090716325948800_ckag090-B1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"2026090716325948800_ckag090-B2","doi-asserted-by":"publisher","first-page":"1405204","DOI":"10.3389\/fendo.2024.1405204","article-title":"Disease burden of breast cancer and risk factors in Europe 44 countries, 1990-2019: findings of the global burden of disease study 2019","volume":"15","author":"Yu","year":"2024","journal-title":"Front Endocrinol"},{"key":"2026090716325948800_ckag090-B3","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.ejca.2019.12.010","article-title":"Evidence for reducing cancer-specific mortality due to screening for breast cancer in Europe: a systematic review","volume":"127","author":"Zielonke","year":"2020","journal-title":"Eur J Cancer"},{"key":"2026090716325948800_ckag090-B4","doi-asserted-by":"publisher","first-page":"2353","DOI":"10.1056\/NEJMsr1504363","article-title":"Breast-cancer screening\u2013viewpoint of the IARC Working Group","volume":"372","author":"Lauby-Secretan","year":"2015","journal-title":"N Engl J Med"},{"key":"2026090716325948800_ckag090-B5","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1016\/j.ejca.2008.11.032","article-title":"Evaluation of data quality in the cancer registry: principles and methods. Part I: comparability, validity and timeliness","volume":"45","author":"Bray","year":"2009","journal-title":"Eur J Cancer"},{"key":"2026090716325948800_ckag090-B6","doi-asserted-by":"publisher","first-page":"2362","DOI":"10.1200\/JCO.2011.37.6434","article-title":"Human epidermal growth factor receptor 2 status and interval breast cancer in a population-based cancer registry study","volume":"30","author":"Musolino","year":"2012","journal-title":"J Clin Oncol"},{"key":"2026090716325948800_ckag090-B7","first-page":"97","volume-title":"Standards and Guidelines for Cancer Registration in Europe: The ENCR Recommendations.","author":"Tyczy\u0144ski","year":"2003"},{"key":"2026090716325948800_ckag090-B8"},{"key":"2026090716325948800_ckag090-B9","doi-asserted-by":"publisher","first-page":"467","DOI":"10.7326\/M18-0850","article-title":"PRISMA extension for scoping reviews (PRISMA-ScR): checklist and explanation","volume":"169","author":"Tricco","year":"2018","journal-title":"Ann Intern Med"},{"key":"2026090716325948800_ckag090-B10","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1186\/s13643-016-0384-4","article-title":"Rayyan\u2014a web and mobile app for systematic reviews","volume":"5","author":"Ouzzani","year":"2016","journal-title":"Syst Rev"},{"key":"2026090716325948800_ckag090-B11","doi-asserted-by":"publisher","first-page":"64","DOI":"10.3389\/fpubh.2019.00064","article-title":"RE-AIM planning and evaluation framework: adapting to new science and practice with a 20-year review","volume":"7","author":"Glasgow","year":"2019","journal-title":"Front Public Health"},{"key":"2026090716325948800_ckag090-B12","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1093\/aje\/kwn120","article-title":"Correcting for lead time and length bias in estimating the effect of screen detection on cancer survival","volume":"168","author":"Duffy","year":"2008","journal-title":"Am J Epidemiol"},{"key":"2026090716325948800_ckag090-B13","author":"European Commission, Joint Research Centre (JRC). European guidelines on breast cancer screening and diagnosis","year":"2025"},{"key":"2026090716325948800_ckag090-B14","doi-asserted-by":"publisher","first-page":"641","DOI":"10.3332\/ecancer.2016.641","article-title":"Cancer registries in Europe\u2014going forward is the only option","volume":"10","author":"Forsea","year":"2016","journal-title":"Ecancermedicalscience"},{"key":"2026090716325948800_ckag090-B15","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1016\/j.ejca.2014.07.016","article-title":"Uses of cancer registries for public health and clinical research in Europe: results of the European Network of Cancer Registries survey among 161 population-based cancer registries during 2010\u20132012","volume":"51","author":"Siesling","year":"2015","journal-title":"Eur J Cancer (1965)"},{"key":"2026090716325948800_ckag090-B16","author":"Breast Cancer Surveillance Consortium (BCSC)","year":"2025"},{"key":"2026090716325948800_ckag090-B17","doi-asserted-by":"publisher","first-page":"481","DOI":"10.7326\/0003-4819-155-8-201110180-00004","article-title":"Cumulative probability of false-positive recall or biopsy recommendation after 10 years of screening mammography","volume":"155","author":"Hubbard","year":"2011","journal-title":"Ann Intern Med"},{"key":"2026090716325948800_ckag090-B18","doi-asserted-by":"publisher","first-page":"3289","DOI":"10.1002\/cncr.32939","article-title":"New mammography screening performance metrics based on the entire screening episode","volume":"126","author":"Sprague","year":"2020","journal-title":"Cancer"},{"key":"2026090716325948800_ckag090-B19","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/S0140-6736(10)62231-3","article-title":"Cancer survival in Australia, Canada, Denmark, Norway, Sweden, and the UK, 1995\u20132007 (the International Cancer Benchmarking Partnership): an analysis of population-based cancer registry data","volume":"377","author":"Coleman","year":"2011","journal-title":"Lancet"},{"key":"2026090716325948800_ckag090-B20","doi-asserted-by":"publisher","first-page":"dju261","DOI":"10.1093\/jnci\/dju261","article-title":"Pan-Canadian study of mammography screening and mortality from breast cancer","volume":"106","author":"Coldman","year":"2014","journal-title":"J Natl Cancer Inst"},{"key":"2026090716325948800_ckag090-B21","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1258\/jms.2012.011127","article-title":"Mammography screening and breast cancer mortality in Australia: an aggregate cohort study","volume":"19","author":"Morrell","year":"2012","journal-title":"J Med Screen"},{"key":"2026090716325948800_ckag090-B22","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1007\/s10552-017-0995-7","article-title":"The performance of mobile screening units in a breast cancer screening program in Brazil","volume":"29","author":"Greenwald","year":"2018","journal-title":"Cancer Causes Control"},{"key":"2026090716325948800_ckag090-B23","author":"European Commission, DG SANTE; EUCanScreen consortium. EUCanScreen\u2014Public Health\u2014European Commission","year":"2025"},{"key":"2026090716325948800_ckag090-B24","author":"International Agency for Research on Cancer (IARC) and CanScreen-ECIS consortium. CanScreen-ECIS","year":"2025"}],"container-title":["European Journal of Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/eurpub\/article-pdf\/36\/4\/ckag090\/68543192\/ckag090.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eurpub\/article-pdf\/36\/4\/ckag090\/68543192\/ckag090.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T20:33:01Z","timestamp":1788813181000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurpub\/article\/doi\/10.1093\/eurpub\/ckag090\/8710032"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,10]]},"references-count":24,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,6,10]]}},"URL":"https:\/\/doi.org\/10.1093\/eurpub\/ckag090","relation":{},"ISSN":["1464-360X"],"issn-type":[{"value":"1464-360X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,8]]},"published":{"date-parts":[[2026,6,10]]},"article-number":"ckag090"}}